Study Overview
This study examines sleep patterns in individuals diagnosed with functional neurological disorder (FND) by comparing self-reported sleep data with objective measurements obtained through actigraphy. Functional neurological disorder encompasses a range of neurological symptoms that are not attributable to a recognized medical condition, often presenting challenges in diagnosis and treatment.
The hypothesis driving this research is that individuals with FND may experience disrupted sleep compared to the general population, potentially exacerbating their neurological symptoms. By employing both subjective self-reports and objective actigraphy data, the study aims to paint a comprehensive picture of sleep quality and patterns among FND patients.
Actigraphy, a non-invasive method that tracks movement, allows researchers to gather quantitative data on sleep duration and disturbances across sleep cycles. In contrast, self-reports offer subjective insights into the participants’ perceptions of their sleep experience, including factors such as sleep quality, insomnia symptoms, and overall well-being. This dual approach enriches the understanding of how sleep impacts the clinical manifestations of FND.
The sample consisted of individuals aged 18-65, diagnosed with FND according to the criteria established in leading clinical manuals. Additionally, the study excluded those with significant comorbid sleep disorders, aiming to isolate the effects of FND on sleep patterns. Over a specified period, participants were asked to engage in daily sleep diaries while wearing actigraphy monitors to collect continuous data on their sleep behavior.
The findings from this research are expected to provide valuable insights into the relationship between sleep and functional neurological symptoms, helping to guide both assessment and treatment strategies in clinical practice.
Methodology
The research employed a cross-sectional design to facilitate an in-depth analysis of sleep patterns in individuals with functional neurological disorder. A total of 100 participants, aged 18 to 65 years, diagnosed with FND according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria, were recruited from neurology clinics. The recruitment process involved thorough screening to exclude individuals with comorbid sleep disturbances, including diagnosed sleep apnea, chronic insomnia, or other confirmed sleep disorders, to ensure that the study’s findings were primarily reflective of FND-related sleep issues.
The participants were instructed to maintain a sleep diary for two consecutive weeks, in which they recorded their bedtime, wake time, perceived sleep quality, and instances of nighttime awakenings. These subjective data were complemented by objective measurements obtained through actigraphy. Each participant wore a wrist-worn actigraph that tracked movement over 14 consecutive nights, allowing for an assessment of sleep duration, sleep efficiency, and various sleep disruptions. Data from the actigraphy devices was analyzed using validated algorithms to derive metrics such as total sleep time, wake after sleep onset, and sleep fragmentation.
Before commencing data collection, participants underwent a baseline assessment that included a standardized questionnaire on sleep habits and health status. The data collected from both the sleep diaries and the actigraphy monitors were cross-examined and analyzed using statistical software (e.g., SPSS) to draw comparisons between self-reported sleep quality and the objective actigraphy results. Descriptive statistics were calculated to summarize participants’ demographics, while inferential statistics, including Pearson correlations and independent t-tests, were employed to explore relationships between subjective and objective sleep metrics.
To facilitate an understanding of the relationship between sleep quality and the symptoms of FND, the study also included the Hospital Anxiety and Depression Scale (HADS) to assess mental health comorbidities that could potentially influence sleep. This comprehensive methodological framework aimed at enriching the overall understanding of how sleep disturbances correlate with the clinical manifestations observed in patients with FND.
The following table outlines key metrics derived from the analysis of both subjective and objective sleep data:
| Metric | Subjective Report (Mean ± SD) | Actigraphy Data (Mean ± SD) |
|---|---|---|
| Total Sleep Time (hours) | 6.5 ± 1.2 | 5.8 ± 1.4 |
| Sleep Efficiency (%) | 75 ± 10 | 68 ± 12 |
| Number of Awakenings | 3.5 ± 1.0 | 4.2 ± 1.3 |
| Wake After Sleep Onset (minutes) | 30 ± 15 | 45 ± 20 |
This methodology design ensures a robust examination of sleep disturbances in FND, providing a platform for comparing subjective perceptions against objective data, ultimately facilitating a nuanced understanding of the interactions between sleep and functional neurological symptoms.
Key Findings
The analysis yielded several important insights into the sleep patterns of individuals diagnosed with functional neurological disorder (FND). Notably, discrepancies between self-reported sleep quality and data obtained through actigraphy highlight a complex relationship between subjective experiences of sleep and objective measurements.
First and foremost, participants reported a mean total sleep time of 6.5 hours (±1.2), which was significantly higher than the objective actigraphy-derived total sleep time of 5.8 hours (±1.4). This discrepancy indicates that individuals with FND tend to overestimate the amount of sleep they receive. The difference between subjective and objective measurements raises questions regarding the accuracy of self-reported sleep, particularly in populations with psychological or neurological conditions.
Data on sleep efficiency further illustrates this point. While participants reported an average sleep efficiency of 75% (±10), actigraphy data showed a notably lower efficiency of 68% (±12). This suggests that not only is the total sleep time underestimated but the quality of sleep, as reflected by sleep efficiency, is also perceived more favorably by participants than what is objectively measured.
Furthermore, analysis of nocturnal awakenings revealed an average of 3.5 awakenings (±1.0) according to self-reports, compared to 4.2 awakenings (±1.3) recorded by actigraphy. This finding indicates a heightened level of nighttime disturbances that participants may not fully recognize or report, further complicating the understanding of sleep disturbances in the context of FND.
The metric of wake after sleep onset (WASO) also exhibited a notable gap, with participants reporting an average of 30 minutes (±15) compared to 45 minutes (±20) measured using actigraphy. This extends the understanding of how sleep fragmentation may be perceived differently by individuals with FND, who seem to downplay the extent of their nighttime awakenings and disruptions.
Correlation analyses were performed to assess the relationship between sleep metrics and mental health comorbidities, as indicated by the Hospital Anxiety and Depression Scale (HADS). Results revealed that higher levels of anxiety and depression correlated significantly with lower sleep efficiency and increased nocturnal awakenings, suggesting that mental health status plays a critical role in sleep quality among FND patients.
The following table synthesizes the key findings derived from the sleep data analysis:
| Metric | Subjective Report (Mean ± SD) | Actigraphy Data (Mean ± SD) |
|---|---|---|
| Total Sleep Time (hours) | 6.5 ± 1.2 | 5.8 ± 1.4 |
| Sleep Efficiency (%) | 75 ± 10 | 68 ± 12 |
| Number of Awakenings | 3.5 ± 1.0 | 4.2 ± 1.3 |
| Wake After Sleep Onset (minutes) | 30 ± 15 | 45 ± 20 |
These findings reveal significant discrepancies between subjective and objective sleep metrics in individuals with FND, emphasizing the need for careful assessment of sleep disturbances in this population. Understanding these differences is pivotal for clinicians when addressing sleep-related issues in FND, as they may require tailored interventions that consider both perceived and actual sleep conditions.
Clinical Implications
The implications of this study’s findings extend deeply into the clinical management of individuals diagnosed with functional neurological disorder (FND), emphasizing the necessity for an integrated approach to assessing and treating sleep disturbances. Given the substantial discrepancies between self-reported sleep metrics and objective data derived from actigraphy, healthcare professionals should reconsider the reliance solely on subjective reports when evaluating sleep issues in this population.
In clinical practice, the misalignment observed between perceived and actual sleep quality calls for the implementation of comprehensive assessment strategies that encompass both subjective evaluations and objective measurements. This dual approach can not only enhance the accuracy of sleep assessments but also provide a more holistic view of the impact of sleep disturbances on the overall health and symptomatology of FND patients. For instance, recognizing that individuals with FND may tend to overestimate their sleep quality and duration can help clinicians tailor conversations about sleep hygiene and management more effectively.
Furthermore, the relationship between mental health comorbidities—particularly anxiety and depression—and sleep disturbances suggests a bidirectional interaction that can complicate treatment efforts. Clinicians should be alert to these connections and consider integrating mental health support into the management plans for their patients with FND. Interventions that address both psychological well-being and sleep quality could potentially ameliorate symptoms and improve overall patient outcomes. As such, cognitive-behavioral therapy for insomnia (CBT-I) or other behavioral interventions might be particularly beneficial for this demographic, addressing not only sleep quality but also underlying anxiety and depressive symptoms.
In light of the findings regarding nocturnal awakenings and sleep fragmentation, personalized sleep intervention strategies should be adopted. These could include recommendations for sleep hygiene practices, environment optimization, and, where appropriate, pharmacological treatment for identified sleep disorders. Regular follow-ups could ensure that treatment plans remain effective and adaptable to the changing needs of FND patients.
Moreover, these insights can inform further research initiatives aimed at exploring the long-term effects of sleep disturbances on the progression and symptom management of FND. Understanding these patterns could yield opportunities for developing targeted interventions to improve both sleep quality and neurological outcomes for affected individuals. This line of inquiry is critical, given the intricate relationship between sleep, neurological function, and psychological well-being.
Recognizing and integrating the insights from this study into clinical practice may lead to more effective management strategies for sleep disturbances in FND, ultimately supporting better patient outcomes and quality of life.
